Q1 2021 Holdings
Filed 2021-05-17 | 89 holdings | $24.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Atricure Inc(ATRC) | COM | 04963C209 | $8.4M | 128,529 | 34.0% |
| Accuray Inc(ARAY) | COM | 004397105 | $4.7M | 941,800 | 18.8% |
| Ascendis Pharma A S(ASND) | SPONSORED ADR | 04351P101 | $3.0M | 23,237 | 12.1% |
| Alector Inc(ALEC) | COM | 014442107 | $2.6M | 127,500 | 10.4% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $2.1M | 83,000 | 8.6% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $2.0M | 223,554 | 7.9% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $1.6M | 57,600 | 6.5% |
| Stereotaxis Inc(STXS) | COM NEW | 85916J409 | $91.9K | 13,680,554 | 0.4% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $25.9K | 314,360 | 0.1% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $20.2K | 207,911 | 0.1% |
| Dicerna Pharmaceuticals Inc(DRNAUSD) | COM | 253031108 | $15.0K | 587,756 | 0.1% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $13.6K | 181,306 | 0.1% |
| Morphic Holding Inc | COM | 61775R105 | $11.5K | 181,467 | 0.0% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $9.5K | 306,320 | 0.0% |
| Affimed N V | COM | N01045108 | $7.8K | 989,857 | 0.0% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $7.8K | 331,661 | 0.0% |
| Dexcom Inc(DXCM) | COM | 252131107 | $7.6K | 21,138 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $7.3K | 406,535 | 0.0% |
| Proqr Therapeutics N V | SHS EURO | N71542109 | $7.3K | 1,100,000 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $7.2K | 73,655 | 0.0% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $6.9K | 151,231 | 0.0% |
| Biohaven Pharmaceuticals Hold(BHVN) | COM | G11196105 | $6.4K | 93,600 | 0.0% |
| Ishares TR Nasdaq Biotech(IBB) | ETF | 464287556 | $6.1K | 40,400 | 0.0% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $5.8K | 75,175 | 0.0% |
| Karuna Therapeutics Inc | COM | 48576A100 | $5.8K | 48,000 | 0.0% |
| Cardiovascular Systems Inc(CSIIEUR) | COM | 141619106 | $5.7K | 149,700 | 0.0% |
| Cara Therapeutics Inc(CARAEUR) | COM | 140755109 | $5.7K | 261,442 | 0.0% |
| Protalix Biotherapeutics Inc(PLX) | COM | 74365A309 | $5.4K | 1,204,825 | 0.0% |
| Arena Pharmaceuticals Inc(ARNAEUR) | COM NEW | 040047607 | $5.3K | 76,715 | 0.0% |
| Adicet BIO Inc(TORCEUR) | COM | 007002108 | $5.0K | 385,077 | 0.0% |
| Aerie Pharmaceuticals Inc(AERIEUR) | COM | 00771V108 | $4.9K | 275,840 | 0.0% |
| Luminex Corp | COM | 55027E102 | $4.9K | 154,091 | 0.0% |
| Hookipa Pharma Inc | COM | 43906K100 | $4.6K | 343,455 | 0.0% |
| Mereo Biopharma Group PLC(MREO) | ADS | 589492107 | $4.2K | 1,249,648 | 0.0% |
| Radius Health Inc | NOTE 3.000% 9/0 | 750469AA6 | $3.7K | $4,000,000 | 0.0% |
| Translate BIO Inc | COM | 89374L104 | $3.7K | 225,393 | 0.0% |
| Redhill Biopharma LTD | SPONSORED ADS | 757468103 | $3.3K | 455,933 | 0.0% |
| Merus N V | COM | N5749R100 | $3.3K | 157,841 | 0.0% |
| Neuronetics Inc(STIM) | COM | 64131A105 | $3.1K | 253,717 | 0.0% |
| FS Development Corp II | COM CL A | 30318F100 | $3.0K | 300,000 | 0.0% |
| Venus Concept Inc | COM | 92332W105 | $2.9K | 1,230,400 | 0.0% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $2.8K | 447,400 | 0.0% |
| Harpoon Therapeutics Inc | COM | 41358P106 | $2.7K | 126,663 | 0.0% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $2.5K | 105,478 | 0.0% |
| Natus Medical Inc | COM | 639050103 | $2.5K | 95,653 | 0.0% |
| Inflarx NV(IFRX) | COM | N44821101 | $2.3K | 600,000 | 0.0% |
| Aslan Pharmaceuticals LTD | ADS | 04522R101 | $2.3K | 677,500 | 0.0% |
| MEI Pharma Inc | COM NEW | 55279B202 | $2.2K | 646,000 | 0.0% |
| Applied Genetic Technol Corp(2GT) | COM | 03820J100 | $2.2K | 430,111 | 0.0% |
| Phasebio Pharmaceuticals Inc | COM | 717224109 | $2.1K | 603,042 | 0.0% |